Slashdot Mirror


Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

3 of 102 comments (clear)

  1. Re:Tax dollars at work. by Jane+Q.+Public · · Score: 3, Informative

    Maybe my tax dollars might save some lives. And maybe we'll see the words 'government' and 'intellectual' in the same sentence more often. Here's hoping.

    It's interesting that OP claims the government "owns" the "IP" related to the vaccine.

    In the U.S. there are very few -- almost no -- circumstances in which the government can "own" rights to patents, inventions, copyrights, ect.

    They can be classified, but not "owned" except under very rare circumstances. While the ideal has been distorted, especially since 2000, the Federal government is still an employee of The People in the States, and doesn't really "own" anything.

  2. There is a better drug in my opinion. by backslashdot · · Score: 3, Informative

    It's called favipiravir, and originates in Japan. It was tested on a few Spanish patients and it seems to have worked. The key difference between favipiravir and the ZMapp mAb is that favipiravir is effective even when given in the later stages of infection.

    1. Re:There is a better drug in my opinion. by RDW · · Score: 5, Informative

      There are three very different agents here:

      ZMapp - engineered antibodies to EBOV.

      Favipiravir - small molecule, presumably made by standard organic synthesis techniques, active against the RNA polymerases (key replication enzymes) of quite a broad range of RNA viruses (including influenza virus).

      VSV-EBOV - (what the Canadians are shipping). A vaccine rather than a treatment, made by using molecular cloning to insert specific EBOV proteins into an unrelated, harmless virus. It will be propagated in mammalian cells rather than the tobacco-plant based method used for ZMapp production.